Reversal of multidrug-resistance using Valspodar® (PSC 833) and doxorubicin in osteosarcoma

E. Cagliero, R. Ferracini, E. Morello, K. Scotlandi, M. C. Manara, P. Buracco, A. Comandone, R. Baroetto Parisi, N. Baldini

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Reversal of multidrug-resistance using Valspodar® (PSC 833) and doxorubicin in osteosarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences